Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer (Q233284)

From EU Knowledge Graph
Revision as of 21:25, 25 November 2021 by DG Regio (talk | contribs) (‎Created claim: summary (P836): Co-targeting PIM-Kinase in medikamentösen Non-Small Cell Lung Cancer, translated_summary)
Jump to navigation Jump to search
Project Q233284 in Ireland
Language Label Description Also known as
English
Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer
Project Q233284 in Ireland

    Statements

    0 references
    16,929.64 Euro
    0 references
    33,859.27 Euro
    0 references
    50.0 percent
    0 references
    1 January 2016
    0 references
    1 January 2018
    0 references
    Trinity College Dublin
    0 references
    Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer (English)
    0 references
    Co-cibler la PIM kinase dans le cancer du poumon non à petites cellules résistant aux médicaments (French)
    25 November 2021
    0 references
    Co-targeting PIM-Kinase in medikamentösen Non-Small Cell Lung Cancer (German)
    25 November 2021
    0 references

    Identifiers

    215
    0 references